We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.91B
AUM Growth
-$33.5M
Cap. Flow
-$96.8M
Cap. Flow %
-1.4%
Top 10 Hldgs %
55.6%
Holding
295
New
67
Increased
47
Reduced
98
Closed
74

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$81.6M
2
NVRO
NEVRO CORP.
NVRO
+$68M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$61.4M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$55.5M
5
KDP icon
Keurig Dr Pepper
KDP
+$44.2M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$105M
2
OGN icon
Organon & Co
OGN
+$75.3M
3
EXAS
Exact Sciences
EXAS
+$69M
4
BIIB icon
Biogen
BIIB
+$57.7M
5
CENTA icon
Central Garden & Pet Co Class A
CENTA
+$53.3M

Sector Composition

Rank Sector Weight
1 Healthcare 39.29%
2 Consumer Staples 5.94%
3 Technology 4.58%
4 Consumer Discretionary 4.41%
5 Communication Services 2.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
26
Microsoft
MSFT
$3.62T
$54.5M 0.79%
160,000
-42,676
-21% -$13.4M
CL icon
27
Colgate-Palmolive
CL
$71.9B
$46.3M 0.67%
601,000
-345,000
-36% -$26.7M
AUPH icon
28
Aurinia Pharmaceuticals
AUPH
$1.87B
$45.4M 0.66%
4,692,000
+520,000
+12% +$5.4M
PARA
29
DELISTED
Paramount Global Class B
PARA
$44.4M 0.64%
2,788,000
+724,000
+35% +$13.1M
EXAS
30
DELISTED
Exact Sciences
EXAS
$44.3M 0.64%
472,000
-884,000
-65% -$69M
POST icon
31
Post Holdings
POST
$4.09B
$44.1M 0.64%
508,410
– –
OFIX icon
32
Orthofix Medical
OFIX
$496M
$44M 0.64%
2,436,000
+600,000
+33% +$11.2M
NVO
33
Novo Nordisk
NVO
$208B
$43.7M 0.63%
540,000
-44,000
-8% -$3.59M
VRTX icon
34
Vertex Pharmaceuticals
VRTX
$119B
$43.6M 0.63%
124,000
-96,000
-44% -$32.3M
ENTA icon
35
Enanta Pharmaceuticals
ENTA
$377M
$43.6M 0.63%
2,036,000
+24,000
+1% +$708K
BHVN icon
36
Biohaven
BHVN
$2.01B
$43.1M 0.62%
1,800,000
-1,324,000
-42% -$22.8M
SWAV
37
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$42.8M 0.62%
150,000
-106,000
-41% -$29.4M
KDP icon
38
Keurig Dr Pepper
KDP
$42.1B
$42.1M 0.61%
+1,347,000
New +$44.2M
VYGR icon
39
Voyager Therapeutics
VYGR
$181M
$41.5M 0.6%
3,624,000
+100,000
+3% +$1.03M
CPB icon
40
Campbell Soup
CPB
$6.67B
$35.7M 0.52%
+780,000
New +$40.2M
EVBG
41
DELISTED
Everbridge, Inc. Common Stock
EVBG
$32.3M 0.47%
1,200,000
+350,000
+41% +$9.44M
PG icon
42
Procter & Gamble
PG
$338B
$31.9M 0.46%
210,000
+206,361
+5,671% +$31.1M
S icon
43
SentinelOne
S
$6.87B
$31.6M 0.46%
2,096,000
+1,560,000
+291% +$26.4M
MDGL icon
44
Madrigal Pharmaceuticals
MDGL
$11.1B
$31.4M 0.45%
136,000
-140,000
-51% -$37.9M
ENR icon
45
Energizer
ENR
$1.45B
$31.2M 0.45%
930,000
+370,000
+66% +$12.4M
DOCU
46
DocuSign
DOCU
$10.5B
$30.2M 0.44%
592,000
+68,000
+13% +$3.6M
KHC icon
47
Kraft Heinz
KHC
$31.3B
$30.2M 0.44%
850,000
– –
MGNX icon
48
MacroGenics
MGNX
$243M
$30M 0.43%
5,600,000
-360,000
-6% -$2.22M
CDNA icon
49
CareDx
CDNA
$2.48B
$28.3M 0.41%
3,324,000
+188,000
+6% +$1.57M
CRSP icon
50
CRISPR Therapeutics
CRSP
$4.88B
$28.1M 0.41%
500,000
-324,000
-39% -$18.4M
1
2
3 4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Armistice Capital held 295 positions worth $6.91B, down 0.48% from $6.94B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital's Q2 2023 filing shows 67 new, 47 increased, 98 reduced and 74 closed positions. Its largest new stake was Pfizer: 2,096,000 shares worth $76.9M. The largest sale was GSK, an estimated $105M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 44% a quarter earlier, followed by Consumer Staples and Technology.

  • Armistice Capital's largest Q2 2023 buy was Pfizer: 2,096,000 shares worth $76.9M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q2 2023, an estimated $55.5M increase.
  • Armistice Capital's biggest Q2 2023 reduction was GSK, cutting an estimated $105M.
  • Armistice Capital fully exited Organon & Co in Q2 2023, selling an estimated $75.3M.
  • Armistice Capital's ten largest holdings make up 56% of its $6.91B portfolio in Q2 2023.
  • Armistice Capital opened 67 new positions and closed 74 in Q2 2023.
  • Armistice Capital's portfolio value fell 0.48% quarter-over-quarter to $6.91B.

Based on Armistice Capital's 13F filing for Q2 2023, filed 14 Aug 2023.